Home/Contractors/Glaxosmithkline PLC

Federal Contractor Profile

Glaxosmithkline PLC

Federal contracting record: $13B obligated across 1,284 awards from 8 agencies, FY 2016–2026.

$13B
Total Obligated
1,284
Award Records
8
Agencies Served
16
NAICS Codes

Company Profile

Parent UEI (Unique Entity Identifier)

CR4UZS5SKL15

CAGE Code

0J8T0

Registered Entities (UEIs)

10 under this organization

Address

200 KIMBALL DR, PARSIPPANY, NJ, 070542173

First Federal Award

Oct 2, 2015

Most Recent Award

Sep 18, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

Top NAICS Activity

  • 325412

    PHARMACEUTICAL PREPARATION MANUFACTURING

    1087 awards

    $5.6B
  • 325411

    MEDICINAL AND BOTANICAL MANUFACTURING

    36 awards

    $5.4B
  • 493120

    REFRIGERATED WAREHOUSING AND STORAGE

    3 awards

    $727M
  • 423450

    MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS

    9 awards

    $683M
  • 325414

    BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

    64 awards

    $194M
  • 541711

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

    7 awards

    $145M
  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    21 awards

    $112M
  • 236210

    INDUSTRIAL BUILDING CONSTRUCTION

    1 awards

    $60M
  • 339112

    SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING

    40 awards

    $45M
  • 446110

    PHARMACIES AND DRUG STORES

    1 awards

    $2.5M

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Sep 18, 2026Department of StateACQUISITIONS - AQM MOMENTUM3254122026 - 2027 FLU VACCINES$687K →
Aug 28, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714FILL/FINISH ADJUVANT (AS03): MULTI-DOSE VIALS$438K →
Aug 20, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412VACCINES FOR CHILDREN$25M →
Aug 18, 2026Department of Health and Human ServicesASPR/ORM-SNS325412RELENZA (ZANAMIVIR) ROTADISK, 5MG$9.1M →
Aug 14, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412VACCINES FOR CHILDREN$183M →
Aug 14, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412VACCINES FOR ADULTS EO 14398$5.1M →
Aug 7, 2026Department of JusticeFBI-JEH325412GSK VACCINES$8K →
Jun 23, 2026Department of Health and Human ServicesASPR/ORM-SNS325412RELENZA (ZANAMIVIR) ROTADISK, 5MG$9.1M →
Jun 9, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412VACCINES FOR CHILDREN$294M →
Jun 8, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412VACCINES FOR ADULTS EO 14398$5.3M →
May 14, 2026Department of JusticeFBI-JEH325412GSK VACCINES$25K →
May 13, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412PEDIATRIC FLU VACCINES$3.8M →
May 7, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325411GSK VACCINES STORAGE AND ROTATION CONTRACT$514K →
May 1, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THE PURPOSE OF THIS TASK ORDER IS TO PROCURE SERVICES FOR STORAGE AND STABILITY VACCINE BULK LOTS FROM PRIOR CONTRACTS FOR U.S. DEPARTMENT OF DEFENSE (DOD) UNDER IDIQ CONTRACT 75A50122D00002 DURING BASE PERIOD YEAR 3. PERIOD OF PERFORMANCE: 2/22/202$176K →
Apr 23, 2026Department of DefenseW7N1 USPFO ACTIVITY TN ARNG325412HEPATITIS A AND B VACCINES FOR TENNESSEE ARMY NATIONAL GUARD.$15K →
Mar 31, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D000002 DURING BASE PERIOD YR. 3. PERIOD OF PERFORMANCE: FEBRUARY$2.7M →
Mar 30, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PROTOTYPE STRAIN$493K →
Mar 27, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412VACCINES FOR CHILDREN$176M →
Mar 13, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412ADULT VACCINES$2.6M →
Mar 13, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412PEDIATRIC FLU VACCINES$77M →
Mar 12, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412ADULT FLU VACCINES$5.0M →
Mar 5, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412ADULT VACCINES$1.6M →
Feb 27, 2026Department of JusticeFBI-JEH325412GSK VACCINES$56K →
Feb 12, 2026Department of JusticeFBI-JEH325412GSK VACCINES$24K →
Feb 5, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES325412VACCINES FOR CHILDREN FY25$78M →

Want to win work like Glaxosmithkline PLC?

Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.